Single-agent Panitumumab in the frail patients with wild-type RAS unresectable colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Panitumumab(6mg/Kg day1) therapy every two weeks
Primary outcome(s): Disease control rate
Study Design: single arm study, open(masking not used), historical control, single assignment, treatment purpose
DISEASE(S): C18-20,Colorectal Cancer
PROVIDER: 2615232 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA